Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fathi

Showing results (51-60 of 206) with videos related to

Pageof 21
Sort By:
Transplantation Proceedings|August 11, 2001
Does recipient age affect the outcome of renal transplantation?M Samhan, M Al-Mousawi, I Al-Muzairai, et al.
Blood|May 21, 2013
FLT3 inhibitor-induced neutrophilic dermatosisAmir T Fathi, Long Le, Robert P Hasserjian, et al.
The New England Journal of Medicine|December 14, 2016
Case 37-2016. An 86-Year-Old Woman with Leukocytosis and SplenomegalyAmir T Fathi, Timothy A Graubert, Naveen M Kulkarni, et al.
Leukemia Research|July 30, 2015
Prior cytopenia predicts worse clinical outcome in acute myeloid leukemiaAmelia Huck, Olga Pozdnyakova, Andrew Brunner, et al.
Experimental Hematology|December 17, 2013
Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutationsAshkan Emadi, Sung Ah Jun, Takashi Tsukamoto, et al.
Leukemia & Lymphoma|January 23, 2024
Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignanciesEytan M Stein, Amir T Fathi, Wael A Harb, et al.
Histopathology|July 23, 2022
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemiaMegan J Fitzpatrick, Leonardo Boiocchi, Amir T Fathi, et al.
Blood Cancer Journal|October 31, 2020
New directions for emerging therapies in acute myeloid leukemia: the next chapterNaval Daver, Andrew H Wei, Daniel A Pollyea, et al.
Critical Reviews in Oncology/Hematology|May 24, 2025
Secondary mutational and cytogenetic alterations in core binding factor - Acute myeloid leukemia (CBF-AML): A systematic review and meta-analysisAmin Javidan, Alireza Azarboo, Sayeh Jalali, et al.
Leukemia|October 11, 2016
Isocitrate dehydrogenase mutations in myeloid malignanciesB C Medeiros, A T Fathi, C D DiNardo, et al.
Pageof 21

Showing results (51-60 of 206) with videos related to

Sort By:
Pageof 21
Transplantation Proceedings|August 11, 2001
Does recipient age affect the outcome of renal transplantation?M Samhan, M Al-Mousawi, I Al-Muzairai, et al.
Blood|May 21, 2013
FLT3 inhibitor-induced neutrophilic dermatosisAmir T Fathi, Long Le, Robert P Hasserjian, et al.
The New England Journal of Medicine|December 14, 2016
Case 37-2016. An 86-Year-Old Woman with Leukocytosis and SplenomegalyAmir T Fathi, Timothy A Graubert, Naveen M Kulkarni, et al.
Leukemia Research|July 30, 2015
Prior cytopenia predicts worse clinical outcome in acute myeloid leukemiaAmelia Huck, Olga Pozdnyakova, Andrew Brunner, et al.
Experimental Hematology|December 17, 2013
Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutationsAshkan Emadi, Sung Ah Jun, Takashi Tsukamoto, et al.
Leukemia & Lymphoma|January 23, 2024
Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignanciesEytan M Stein, Amir T Fathi, Wael A Harb, et al.
Histopathology|July 23, 2022
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemiaMegan J Fitzpatrick, Leonardo Boiocchi, Amir T Fathi, et al.
Blood Cancer Journal|October 31, 2020
New directions for emerging therapies in acute myeloid leukemia: the next chapterNaval Daver, Andrew H Wei, Daniel A Pollyea, et al.
Critical Reviews in Oncology/Hematology|May 24, 2025
Secondary mutational and cytogenetic alterations in core binding factor - Acute myeloid leukemia (CBF-AML): A systematic review and meta-analysisAmin Javidan, Alireza Azarboo, Sayeh Jalali, et al.
Leukemia|October 11, 2016
Isocitrate dehydrogenase mutations in myeloid malignanciesB C Medeiros, A T Fathi, C D DiNardo, et al.
Pageof 21